Discovering Disparities in Diversity: Representation in Clinical Trials
Host: Jennifer Caudle, DO
Guest: Narjust Duma, MD
Are clinical trials really accounting for all patient populations? Dr. Jennifer Caudle joins Dr. Narjust Duma, medical oncologist and assistant professor at the University of Wisconsin School of Medicine and Public Health in Madison, to spre…
ASCO 2022 Highlights
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss the recently completed ASCO meeting with colleagues Dr. Catherine Shu and Dr. Jack West. Dr. Shu is a board-certified medical oncologist specializing in the treatment of thoracic cancers, especially lung…
Strategies for Optimizing Timeliness of Diagnosis & Treatment of Patients with Lung Cancer During Global Crises
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Janani Reisenauer, MD
Guest: Colleen Channick, MD, FCCP, DAABIP
A multidisciplinary panel including a medical oncologist, a thoracic surgeon, and an interventional pulmonologist will …
Updates on Clinical Trials in Oncology & Radiation
Host: Septimiu Murgu, MD, FCCP
Host: Eric Edell, MD, FCCP
Guest: Narjust Duma, MD
Guest: Andreas Rimner, MD
Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoraci…
Optimal Tissue Acquisition, Handling, and Processing NGS and PD-L1 Testing
Host: Eric Edell, MD, FCCP
Host: Septimiu Murgu, MD, FCCP
Guest: Narjust Duma, MD
Guest: Christopher Hartley, MD
Guest: Jeffrey Mueller, DO
Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid bi…
Diagnosing NSCLC: A Look at the Complete Picture
Guest: Narjust Duma, MD
Guest: David J. Feller-Kopman, MD
Guest: Bruce E. Johnson, MD
Guest: Razelle Kurzrock, MD, FACP
Guest: Ignacio Wistuba, MD
Lung cancer incidence is decreasing due in part to reduced smoking rates, and new trends are emerging as things change. But d…
Social Determinants of Health – Modifiable Risk Factors – Tobacco Cessation
This episode was originally released August 23, 2021
In this Social Determinants of Health (SDOH) episode, Dr. Narjust Duma (DFCI) moderates a talk with Dr. Danielle McCarthy (University of Wisconsin-Madison) and Dr. Erica Warner (Harvard Medical School & MGH) on tobacco cessation as a modifiable …
Social Determinants of Health - Living Our Values
This episode was originally released December 9, 2020
In this episode of ASCO eLearning's Social Determinants of Health (SDOH) series, Narjust Duma, MD, moderates a discussion with ASCO CEO, Clifford A. Hudis, MD, FACP, FASCO and Sybil R. Green, JD, RPh, MHA, Director of Strategic Initiatives in A…
Diagnosing NSCLC: A Look at the Complete Picture
Guest: Narjust Duma, MD
Guest: David J. Feller-Kopman, MD
Guest: Bruce E. Johnson, MD
Guest: Razelle Kurzrock, MD, FACP
Guest: Ignacio Wistuba, MD
Lung cancer incidence is decreasing due in part to reduced smoking rates, and new trends are emerging as things change. But d…
PODCAST SØGEMOTOR
Du kan bruge vores hjemmeside til at søge efter3,830,558podcasts og196,657,032episoder efter personer, steder eller emner.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.
